- Home
- DHC vs EU Comparison
DHC vs EU Comparison
Compare DHC & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DHC | EU |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | United States | United States |
| Employees | 585 | N/A |
| Industry | Real Estate Investment Trusts | Other Metals and Minerals |
| Sector | Real Estate | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 464.5M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | DHC | EU |
|---|---|---|
| Price | $6.84 | $1.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $7.25 | $4.00 |
| AVG Volume (30 Days) | 1.9M | ★ 3.2M |
| Earning Date | 05-04-2026 | 03-03-2026 |
| Dividend Yield | ★ 0.56% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $58,334,000.00 |
| Revenue This Year | $4.50 | $17.41 |
| Revenue Next Year | $5.54 | $95.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 163.38 |
| 52 Week Low | $2.00 | $1.01 |
| 52 Week High | $7.66 | $4.19 |
Technical Indicators
Market Signals| Indicator | DHC | EU |
|---|---|---|
| Relative Strength Index (RSI) | 48.91 | 27.44 |
| Support Level | $3.93 | N/A |
| Resistance Level | $6.85 | $2.83 |
| Average True Range (ATR) | 0.37 | 0.13 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 8.16 | 3.42 |
Price Performance
Historical ComparisonAbout DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.